Exhale

The official blog of the Lung Institute.

Kicking the Habit in Downtown Tampa

18 Mar 2015
| Under COPD, Lung Disease, Smoking | Posted by
| 1 Comment
Event Downtown Tampa Lung Institute

Lung Institute hosting 2015 Kick Butts Day Event in the Park

Tampa, FL (March 17, 2015) – On March 18th, thousands of individuals will flood the United States with anti-tobacco campaigns for the 20th annual Kick Butts Day. This year, the Lung Institute is joining the fight for a smoke-free life by hosting an event during lunch in Lykes Gaslight Park. As part of the Kick Butts Day theme of kicking tobacco butts once and for all, Lung Institute team members urge people to quit smoking just for one day; we believe if you can quit for one day, you may be inspired to quit forever.

In an effort to lower the number of smoking-related illnesses, the Lung Institute will raise public awareness by offering a kick-off contest and a chance to play in the park. With opportunities to win prizes, take home giveaways and engage with team members, the Lung Institute encourages citizens to join in the fun in downtown Tampa on Kick Butts Day.

Kick Butts Day is a national day of activism that empowers individuals to become health advocates and speak out against Big Tobacco. Kick Butts Day is organized by the Campaign for Tobacco-Free Kids, a leading force in the fight to reduce tobacco use and its deadly total. Recent statistics estimate that smoking kills more than 480,000 people annually; 25 percent of those deaths are from a chronic lung disease like COPD.

As a leading cause of debilitating lung diseases such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease, the health advocates at the Lung Institute hope to raise awareness about the risks of smoking. It is estimated that smoking causes nearly 80 percent of COPD deaths. Quitting smoking is the first step to a disease-free life. For those already diagnosed, kicking the tobacco habit could greatly increase quality of life. 

Join us for Kick Butts Day:

When: Wednesday, March 18, 2015 from 11 a.m. to 2 p.m.

Where: Lykes Gaslight Square Park in Tampa, FL. 


About the Lung Institute

At the Lung Institute, we are changing people’s lives across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive cellular therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.